ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
Malzo
|
111 |
46K |
5 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
111
|
46K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
Malzo
|
111 |
46K |
3 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
111
|
46K
|
3
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Investor Presentation - Battery Metals Conference 2023
|
|
Malzo
|
60 |
31K |
2 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
60
|
31K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Results of Concrete Decarbonisation Study
|
|
Malzo
|
355 |
114K |
4 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
355
|
114K
|
4
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Becoming a substantial holder
|
|
Malzo
|
9 |
3.9K |
0 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
9
|
3.9K
|
0
|
|
ASX - By Stock
|
CCZ |
Re:
Ann: Becoming a substantial holder
|
|
Malzo
|
9 |
3.9K |
1 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
9
|
3.9K
|
1
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Monoova Signs Identitii Licence Agreement
|
|
Malzo
|
33 |
12K |
3 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
33
|
12K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
7 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
44K
|
21M
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Successful Completion of DSMB Review of Phase 3 FSGS Trial
|
|
Malzo
|
32 |
13K |
3 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
32
|
13K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
4 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
44K
|
21M
|
4
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
4 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
44K
|
21M
|
4
|
|
ASX - By Stock
|
ADN |
Re:
Ann: PEPR Approved for Great White Project
|
|
Malzo
|
241 |
87K |
6 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
241
|
87K
|
6
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
3 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
44K
|
21M
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Half-Year Financial Report & Appendix 4D - 31 December 2022
|
|
Malzo
|
18 |
7.7K |
5 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
18
|
7.7K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
41 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
44K
|
21M
|
41
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Half-Year Financial Report & Appendix 4D - 31 December 2022
|
|
Malzo
|
18 |
7.7K |
4 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
18
|
7.7K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DXB to Receive $2.8m in Prepayment of R&D Tax Incentive
|
|
Malzo
|
57 |
19K |
5 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
57
|
19K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: REMAP-CAP COVID-19 Study Analysis Update
|
|
Malzo
|
76 |
24K |
3 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
76
|
24K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
5 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
44K
|
21M
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Successful Completion of DSMB Review of Phase 3 FSGS Trial
|
|
Malzo
|
32 |
13K |
4 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
32
|
13K
|
4
|
|
ASX - By Stock
|
IPT |
Re:
commonwealth prospect
|
|
Malzo
|
13 |
5.8K |
1 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
13
|
5.8K
|
1
|
|
ASX - By Stock
|
ID8 |
Re:
Identitii (ASX:ID8) provides insight into the global trend of changing financial crime reporting
|
|
Malzo
|
35 |
13K |
3 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
35
|
13K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Resignation of Chief Financial Officer
|
|
Malzo
|
69 |
30K |
9 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
69
|
30K
|
9
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
9 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
44K
|
21M
|
9
|
|
ASX - By Stock
|
IPT |
Re:
IPT Chart
|
|
Malzo
|
477 |
196K |
4 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
477
|
196K
|
4
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Change of Director's Interest Notice
|
|
Malzo
|
24 |
10K |
4 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
24
|
10K
|
4
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Change of Director's Interest Notice
|
|
Malzo
|
24 |
10K |
7 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
24
|
10K
|
7
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda appoints General Counsel and Company Secretary
|
|
Malzo
|
25 |
9.9K |
8 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
25
|
9.9K
|
8
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda appoints General Counsel and Company Secretary
|
|
Malzo
|
25 |
9.9K |
5 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
25
|
9.9K
|
5
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
6 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
44K
|
21M
|
6
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
11 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
44K
|
21M
|
11
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
0 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
44K
|
21M
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FDA Confirms Inclusion of Paediatrics in ACTION3 Study
|
|
Malzo
|
33 |
10K |
2 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FDA Confirms Inclusion of Paediatrics in ACTION3 Study
|
|
Malzo
|
33 |
10K |
2 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
33
|
10K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
3 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
44K
|
21M
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved
|
|
Malzo
|
37 |
15K |
0 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
37
|
15K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved
|
|
Malzo
|
37 |
15K |
1 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
37
|
15K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: DMX-200 FSGS Phase 3 Trial Part 1 Recruitment Achieved
|
|
Malzo
|
37 |
15K |
2 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
37
|
15K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
General comments/chat
|
|
Malzo
|
44K |
21M |
11 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
44K
|
21M
|
11
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Drilling at Broken Hill to Commence this Week
|
|
Malzo
|
139 |
57K |
2 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
139
|
57K
|
2
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Notification of cessation of securities - ADN
|
|
Malzo
|
23 |
9.6K |
14 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
23
|
9.6K
|
14
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Chair address and CEO presentation to AGM
|
|
Malzo
|
26 |
9.6K |
3 |
02/12/22 |
02/12/22 |
ASX - By Stock
|
26
|
9.6K
|
3
|
|
ASX - By Stock
|
NAE |
Re:
Ann: Strong Lithium Geochemical Anomalies identified Pilbara WA
|
|
Malzo
|
88 |
28K |
0 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
88
|
28K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Briefing
|
|
Malzo
|
27 |
7.6K |
2 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
27
|
7.6K
|
2
|
|
ASX - By Stock
|
IPT |
Re:
IPT Chart
|
|
Malzo
|
477 |
196K |
10 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
477
|
196K
|
10
|
|
ASX - By Stock
|
CCZ |
Re:
CCZ: Amazing (Cobalt and Rare Earth Elements)
|
|
Malzo
|
59 |
22K |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
59
|
22K
|
0
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Investor Presentation - Noosa Mining Conference
|
|
Malzo
|
47 |
23K |
16 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
47
|
23K
|
16
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Quarterly Reports - September 2022
|
|
Malzo
|
89 |
34K |
13 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
89
|
34K
|
13
|
|
ASX - By Stock
|
DXB |
Re:
Subtle hint
|
|
Malzo
|
30 |
11K |
8 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
30
|
11K
|
8
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Andromeda Appoints Joe Ranford as Chief Operating Officer
|
|
Malzo
|
85 |
29K |
3 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
85
|
29K
|
3
|
|